| 20th Mar 2025 11:10 am |
RNS |
Result of AGM |
| 28th Feb 2025 12:30 pm |
RNS |
Total Voting Rights |
| 14th Feb 2025 2:18 pm |
RNS |
Posting of Annual Report and Notice of AGM |
| 30th Jan 2025 7:00 am |
RNS |
£168,750 Placing |
| 29th Jan 2025 7:00 am |
RNS |
Annual Results for period ended 30 September 2024 |
| 28th Jan 2025 7:00 am |
RNS |
NXP002 ODD Application Submitted |
| 13th Jan 2025 7:00 am |
RNS |
NXP002 Orphan Drug Designation Draft Application |
| 29th Nov 2024 5:00 pm |
RNS |
Total Voting Rights |
| 5th Nov 2024 2:25 pm |
RNS |
Director/PDMR Dealings |
| 4th Nov 2024 10:17 am |
RNS |
Result of General Meeting |
| 16th Oct 2024 1:37 pm |
RNS |
Publication of Prospectus & Notice of GM |
| 20th Sep 2024 2:24 pm |
RNS |
£300,000 Fundraise |
| 18th Jun 2024 7:00 am |
RNS |
Half-year Report |
| 17th Jun 2024 7:00 am |
RNS |
Patent Update |
| 19th Mar 2024 2:39 pm |
RNS |
Result of AGM |
| 1st Mar 2024 7:00 am |
RNS |
Subscription to raise £150,000 |
| 15th Jan 2024 11:30 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 3rd Jan 2024 7:00 am |
RNS |
Results for the period ended 30 September 2023 |
| 18th Dec 2023 7:00 am |
RNS |
NXP001 Update |
| 23rd Oct 2023 7:00 am |
RNS |
Notice of Allowance of NXP002 Patent in Japan |
| 18th Sep 2023 7:00 am |
RNS |
NXP001 Update |
| 24th Aug 2023 1:22 pm |
RNS |
Result of Annual General Meeting |
| 31st Jul 2023 2:00 pm |
RNS |
Notice of AGM |
| 26th Jul 2023 2:55 pm |
RNS |
Holding(s) in Company |
| 2nd Jun 2023 7:00 am |
RNS |
Investor Online Q&A |
| 25th May 2023 7:00 am |
RNS |
Change of Auditor |
| 22nd May 2023 7:00 am |
RNS |
Unaudited Interim Report |
| 18th May 2023 7:00 am |
RNS |
NXP002 Inflammation and Duration of Action Update |
| 26th Apr 2023 10:55 am |
RNS |
Holding(s) in Company |
| 17th Apr 2023 7:00 am |
RNS |
Subscription to raise £70,000 & issue of Warrants |
| 27th Mar 2023 7:00 am |
RNS |
NXP002 Update |
| 13th Mar 2023 7:00 am |
RNS |
Change of Accounting Reference Date |
| 15th Feb 2023 7:00 am |
RNS |
NXP002 Update |
| 3rd Jan 2023 1:37 pm |
RNS |
Holding(s) in Company |
| 20th Dec 2022 1:02 pm |
EQS |
Nuformix hoping to 'initiate discussions with major pharma' in 2023 |
| 20th Dec 2022 7:00 am |
RNS |
NXP004 Update |
| 13th Dec 2022 7:00 am |
RNS |
Half-year Report |
| 5th Dec 2022 7:00 am |
RNS |
Resignation of Auditor |
| 16th Nov 2022 8:50 am |
RNS |
Holding(s) in Company |
| 4th Nov 2022 7:00 am |
RNS |
Investor Webinar |
